Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FM164
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,674
Award facts
- Contract value 100% obligated
- $41,673.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order valued at $41,673.78 from the Defense Logistics Agency on January 8, 2026, for pharmaceutical products and medical supplies to support federal healthcare needs. This firm fixed-price, non-set-aside contract is scheduled for completion by January 9, 2026, with performance at the company's Conshohocken, Pennsylvania facility. The delivery order falls under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 and extending through December 2026.
Amerisourcebergen serves as a critical pharmaceutical distributor for the Defense Logistics Agency's Medical Supply Chain, supplying an extensive portfolio of prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal procurement history demonstrates consistent capability to compete on a full and open basis and efficiently fulfill government contracts for essential medical products required by military treatment facilities, veterans' healthcare programs, and other federal medical institutions. DLA Troop Support is planning to establish next-generation pharmaceutical prime vendor contracts with potential multiple awards across separate regions, positioning Amerisourcebergen competitively within this strategic modernization effort.
Quick answers
Who was awarded contract SPE2DU26FM164?
SPE2DU26FM164 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DU26FM164 worth?
The government has obligated $41,674 on SPE2DU26FM164.
Is contract SPE2DU26FM164 an order under another contract?
Yes. SPE2DU26FM164 is a delivery order under SPE2DU25D4118, an indefinite delivery contract.
Was contract SPE2DU26FM164 competed?
The extent of competition for SPE2DU26FM164 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award